Lantz Financial’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.17M | Sell |
5,291
-28
| -0.5% | -$7.75K | 0.21% | 114 |
|
|
2026
Q1 | $1.57M | Buy |
5,319
+537
| +11% | +$160K | 0.32% | 84 |
|
|
2025
Q4 | $1.31M | Buy |
4,782
+884
| +23% | +$240K | 0.28% | 97 |
|
|
2025
Q3 | $1.05M | Sell |
3,898
-34
| -0.9% | -$9.25K | 0.23% | 112 |
|
|
2025
Q2 | $1.08M | Buy |
3,932
+44
| +1% | +$12K | 0.27% | 92 |
|
|
2025
Q1 | $1.03M | Sell |
3,888
-19
| -0.5% | -$4.69K | 0.28% | 92 |
|
|
2024
Q4 | $907K | Sell |
3,907
-456
| -10% | -$105K | 0.24% | 98 |
|
|
2024
Q3 | $963K | Buy |
4,363
+36
| +0.8% | +$7.45K | 0.26% | 89 |
|
|
2024
Q2 | $851K | Sell |
4,327
-234
| -5% | -$48.3K | 0.26% | 94 |
|
|
2024
Q1 | $982K | Buy |
4,561
+49
| +1% | +$10.3K | 0.32% | 82 |
|
|
2023
Q4 | $950K | Buy |
4,512
+7
| +0.2% | +$1.49K | 0.34% | 78 |
|
|
2023
Q3 | $902K | Sell |
4,505
-250
| -5% | -$49.7K | 0.36% | 78 |
|
|
2023
Q2 | $881K | Sell |
4,755
-92
| -2% | -$17K | 0.35% | 80 |
|
|
2023
Q1 | $928K | Hold |
4,847
| – | – | 0.39% | 74 |
|
|
2022
Q4 | $815K | Hold |
4,847
| – | – | 0.37% | 72 |
|
|
2022
Q3 | $859K | Sell |
4,847
-127
| -3% | -$25.1K | 0.45% | 60 |
|
|
2022
Q2 | $1.02M | Sell |
4,974
-200
| -4% | -$42.4K | 0.46% | 64 |
|
|
2022
Q1 | $1.23M | Sell |
5,174
-100
| -2% | -$23.5K | 0.5% | 61 |
|
|
2021
Q4 | $1.21M | Hold |
5,274
| – | – | 0.55% | 52 |
|
|
2021
Q3 | $1.02M | Sell |
5,274
-25
| -0.5% | -$5.07K | 0.52% | 56 |
|
|
2021
Q2 | $1.13M | Hold |
5,299
| – | – | 0.58% | 52 |
|
|
2021
Q1 | $1.08M | Hold |
5,299
| – | – | 0.62% | 46 |
|
|
2020
Q4 | $965K | Hold |
5,299
| – | – | 0.6% | 47 |
|
|
2020
Q3 | $887K | Sell |
5,299
-22
| -0.4% | -$3.71K | 0.6% | 51 |
|
|
2020
Q2 | $865K | Hold |
5,321
| – | – | 0.62% | 52 |
|
|
2020
Q1 | $920K | Hold |
5,321
| – | – | 0.72% | 45 |
|
|
2019
Q4 | $1.07M | Sell |
5,321
-10
| -0.2% | -$2.05K | 0.63% | 56 |
|
|
2019
Q3 | $1.11M | Sell |
5,331
-14
| -0.3% | -$2.92K | 0.75% | 49 |
|
|
2019
Q2 | $1.07M | Hold |
5,345
| – | – | 0.72% | 48 |
|
|
2019
Q1 | $880K | Buy |
+5,345
| New | +$945K | 0.64% | 54 |
|
Other funds holding CME
Lantz Financial's CME Position: Q2 2026 in Review
Lantz Financial reduced its CME Group (CME) stake by 0.53% in Q2 2026, selling an estimated $7.75K and leaving 5,291 shares worth $1.17M. The position accounts for 0.21% of the portfolio, ranked #114.
Lantz Financial first reported a position in CME in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.57M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Lantz Financial held 5,291 shares of CME Group worth $1.17M as of Q2 2026.
- Lantz Financial sold 28 CME Group shares in Q2 2026, an estimated $7.75K.
- CME Group made up 0.21% of Lantz Financial's portfolio in Q2 2026, its #114 holding.
- Lantz Financial first reported a position in CME Group in Q1 2019 and has held it in 30 quarters since.
- Lantz Financial's CME Group position peaked at $1.57M in Q1 2026.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.